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        NK cell activation receptors play important roles 
in both viral infection and tumor surveillance. 
One such activation receptor, Ly49H, accounts 
for genetic resistance to murine cytomegalovirus 
(MCMV) (  1  –  3  ). Coupled to the DAP12 signal-
ing chain, Ly49H is expressed on a subset of NK 
cells in C57BL/6 mice (  4  –  6  ) and recognizes the 
MCMV-encoded m157 molecule, a glycophos-
phatidylinositol-linked protein (  7  –  12  ). To date, 
m157 is the only known ligand for the Ly49H 
receptor, and in C57BL/6 mice only Ly49H in-
teracts with m157. 
  Activated NK cells release proinfl  ammatory 
cytokines and cytolytic granules that can ul-
timately destroy the susceptible target cell (  13  ). 
These potent eff  ector responses must be con-
trolled, as NK cells must recognize and distinguish 
the abnormal cells that they destroy from normal 
self-tissues that are spared (  14, 15  ). One mech-
anism to prevent aberrant NK cell activation 
involves inhibitory receptors specifi  c for MHC 
class I molecules on target cells. Engagement of 
these inhibitory receptors delivers negative signals, 
explaining the   “  missing self  ”   hypothesis (  16  ). 
In general, the integration of both positive and 
negative stimuli determines if an NK cell becomes 
activated during eff    ector responses. 
  The MHC class I  –  specifi  c inhibitory recep-
tors also appear to have another function (  17  ). 
Engagement of inhibitory Ly49 receptors by their 
cognate MHC class I ligands, expressed as self-
MHC, allows NK cells to acquire functional 
competence to be triggered through their activa-
tion receptors. In this process, termed licensing, 
the self-MHC class I  –  specifi  c inhibitory receptors 
appear to signal the licensing event because their 
cytoplasmic domains, specifi  cally the immunore-
ceptor tyrosine-based inhibitory motif, are re-
quired (  17  ). Though further understanding of its 
mechanism is required, most groups now agree 
that the engagement of inhibitory receptors by 
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of the m157-Tg mice survived, with deaths beginning around 
the time of onset of lethality in genetically susceptible BALB/c 
mice (  Fig. 1 A  ).   In contrast, all of the WT C57BL/6 litter-
mates survived. In addition, infected m157-Tg mice displayed 
signifi  cantly higher splenic MCMV titers at 3 d after infection 
compared with WT littermates (  Fig. 1 B  ). The m157-Tg mice 
had splenic viral titers comparable to susceptible BALB/c mice. 
To determine if mature m157-Tg splenocytes were defective 
in controlling MCMV outside the context of an m157-Tg 
mouse, we performed adoptive transfer experiments in neo-
natal mice whereby transferred splenocytes provide NK cell  –
  dependent resistance to MCMV infections (  20  ). However, 
neonatal mice were not protected by adoptively transferred 
m157-Tg splenocytes, similar to PBS-treated controls, whereas 
WT splenocytes provided a signifi  cant increase in survival 
(  Fig. 1 C  ). Collectively, these data indicate that m157-Tg 
mice behave similarly to BALB/c mice lacking   Ly49h  , and 
m157-Tg splenocytes are less effi   cient than their WT coun-
terparts in controlling MCMV infection, suggesting a defect 
in m157-Tg Ly49H  +   NK cells. 
self-MHC class I plays an important role in acquisition of NK 
cell function (  14, 15, 18  ). 
  At least two major models have been proposed to account 
for the role of the self-MHC class I  –  specifi  c receptors in licens-
ing (  14, 15  ). One model (  “  arming  ”   or   “  stimulatory  ”   model) 
suggests that the inhibitory receptor directly signals the licensing 
event. Another model (  “  disarming  ”   or   “  inhibitory  ”   model) sug-
gests that, when unimpeded, a self-specifi  c activation receptor 
results in a   “  hyporesponsive  ”   state, akin to peripheral T cell an-
ergy. The self-MHC class I  –  specifi  c inhibitory receptor is postu-
lated to modulate the function of the activation receptor and 
thereby allows licensing to occur. Current data do not allow 
conclusive discrimination between these models (  14, 15  ). To 
more fully understand the potential contribution of self-specifi  c 
NK cell activation receptors to NK cell tolerance and to begin 
testing the disarming (inhibitory receptor) model for licensing, 
we borrowed a strategy that was critical for detailed characteriza-
tion of B and T cell tolerance, i.e., the generation of transgenic 
mice expressing ligands for the BCR and TCR, respectively. 
For example, a foreign antigen (hen egg lysozyme) expressed in 
this context is perceived by the immune system as   “  self,  ”   allowing 
further elucidation of B cell self-tolerance mechanisms (  19  ). This 
transgenic strategy was required because there are few other NK 
cell activation receptors where the ligands are unequivocally de-
fi  ned and are not present in normal mice. Herein, we generated 
mice on the C57BL/6 background that ubiquitously expresses 
m157. These mice displayed a defect in NK cell function that is 
manifested in vivo by increased susceptibility to MCMV infec-
tion, as well as an inability to reject m157-transgenic (m157-Tg) 
BM cell transplants. The data indicate that the persistent engage-
ment of self-activation receptors infl  uences the functional status 
of the mature NK cell. 
    RESULTS   
  Production of m157 transgenic mice 
  We generated a transgenic construct for expression of m157 under 
the control of the human     -actin promoter (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20072446/DC1). 
The construct was directly injected into C57BL/6-derived 
fer  tilized ova. Transgenic founders were identifi  ed by PCR 
geno  typing, as was the cell surface expression of m157 on 
peripheral blood lymphocytes and BM cells. The m157-Tg 
mice were phenotypically normal and healthy. Their growth 
and development were similar to their nontransgenic (WT) 
littermates. As compared with WT mice, they had similar 
numbers of splenocytes and there were no signifi  cant dif-
ferences in the percentages of B or T cells (Fig. S2 and not 
depicted). Thus, even though the m157-Tg mice expressed 
the ligand for the Ly49H activation receptor, they did not 
display any overt signs of autoimmunity. 
  m157-Tg mice are defective in MCMV control 
and BM rejection 
  Because the Ly49H receptor plays a vital role in susceptibility 
to MCMV infection, we assessed responses to MCMV infec-
tion in vivo. After injection of 1.5   ×   10  5   PFU MCMV,   <  50% 
    Figure 1.         Increased mortality and splenic titers in m157-Tg mice 
infected with MCMV.   (A) Survival curve after MCMV infection. BALB/c 
mice (    , 3 per group), m157-Tg (    , 11 per group), or WT littermates (   , 
11 per group) were injected i.p. with 1.5   ×   10  5   PFU MCMV (Smith strain) 
and were followed for 30 d after infection. The percentage of mice surviv-
ing within each group was determined daily. (B) Splenic titers after MCMV 
infection. BALB/c (white,   n   = 9), m157-Tg (gray,   n   = 8), and WT littermates 
(black,   n   = 8) were injected with 2   ×   10  4   PFU MCMV Smith strain. The 
spleens were harvested on day three after infection, and viral titers were 
determined with a standard viral plaque assay. The results are presented 
as Log PFU/spleen (mean   ±   SEM). For one mouse in the WT group with a 
titer below level of detection of this assay, the minimum number of de-
tectable PFU (10  2  ) was assumed to determine the mean. P value deter-
mined using a two-tailed Student  ’  s   t   test. (C) WT, but not m157-Tg, 
splenocytes protect neonatal mice from MCMV infection. Neonatal mice 
were injected i.p. with PBS (   ,   n   = 12), 5   ×   10  7   WT splenocytes (   ,   n   =  11), 
or 5   ×   10  7   m157-Tg splenocytes (   ,   n   = 12). 24 h later, the mice were 
injected i.p. with 870  –  1,000 PFU MCMV. The percentage of mice surviving 
within each group was determined daily. These data are a combination of 
two separate experiments, each of which showed similar results.     JEM VOL. 205, August 4, 2008 
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Ly49H        NK cells (which do not interact with m157) that prob-
ably participate in the rejection of       2  m      /      BM. Taken together 
with the MCMV experiments, these data indicate a defect in the 
response of m157-Tg Ly49H  +   NK cells to m157-expressing tar-
gets (either on MCMV-infected cells or on m157-Tg BM). 
  Down-regulation of Ly49H in vivo 
  There are many potential explanations for the apparent dys-
function of the Ly49H  +   NK cells in the m157-Tg mice. To 
investigate these defects further, we analyzed the expression of 
Ly49H on the surface of peripheral blood and splenic NK 
cells in numerous founders. In all m157-Tg mice examined, 
there was a slight decrease in the measured percentage and 
number of Ly49H  +   NK cells (  Fig. 3   and Fig. S2).   This was 
specifi  c to the Ly49H receptor because the expression of other 
  The presence of normal hematopoiesis in the m157-Tg mice 
suggested that the m157-Tg BM either did not express m157 
or the Ly49H  +   NK cells were tolerized in the m157-Tg mice. 
The observation that m157 was detected on the surface of BM 
cells derived from m157-Tg mice (Fig. S1) suggests that 
Ly49H  +   NK cells in m157-Tg mice were tolerized. To further 
evaluate this possibility, we performed BM transplantation ex-
periments. It has been previously demonstrated that irradiation-
resistant NK cells can reject MHC-defi  cient BM grafts (  21, 22  ) 
or BM-expressing ligands for an activation receptor such as 
NKG2D (  23  ). Similar to these results, we found that the en-
graftment of m157-Tg BM was lower than WT BM in WT 
mice, at every BM dose (  Fig. 2 A  ).   Although engraftment of 
m157-Tg BM was never as low as       2  m      /      BM, rejection by 
WT mice was prevented by depletion of NK cells with the 
anti-NK1.1 mAb or administration of the nondepleting anti-
Ly49H mAb (  Fig. 2 B  ). Therefore, these experiments demon-
strate that WT Ly49H  +   NK cells recognize m157 on m157-Tg 
BM cells, and that WT rejection of m157-Tg BM was NK cell 
dependent, and more specifi  cally, Ly49H dependent. 
  More importantly, the preceding experiments also suggested 
that m157-Tg mice might be tolerant to m157 because of nor-
mal hematopoiesis in the m157-Tg mice. To study this further, 
lethally irradiated m157-Tg mice were injected with 2   ×   10  6   
BM cells from m157-Tg mice. The m157-Tg mice, unlike WT 
mice, failed to reject BM cells from m157-Tg donors (  Fig. 2 B  ). 
Of note, the m157-Tg mice were still able to reject       2  m      /      BM 
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20072446/DC1). This is likely explained by a role for 
    Figure 2.         WT, but not m157-Tg, mice reject m157-Tg BM trans-
plants.   (A) WT C57BL/6 recipient mice were lethally irradiated, and then 
injected i.v. with the indicated number of donor WT (    ), m157-Tg (   ),  or 
    2 m    /     (   ) donor BM cells.   125  I-deoxyuridine uptake was measured in the 
spleen as an index of engraftment. Each point represents an individual 
mouse. The line represents the mean of the log counts per minute (cpm)/
spleen of the group. (B) m157-Tg (  n   = 3) or WT recipient mice were 
  lethally irradiated and then injected i.v. with 2   ×   10  6   m157-Tg donor BM 
cells. WT mice were pretreated 2 d before BM transplant with 200   μ  g i.p. 
of anti-NK1.1 mAb (PK136;   n   = 4), anti-Ly49H mAb (3D10;   n   = 4), or con-
trol mouse anti  –  rat mAb (MAR;   n   = 5).   Fig. 2 B   represents one of two 
similar experiments. P values were determined using Mann-Whitney test. 
There was no statistical difference between m157-Tg recipients and WT 
recipient mice pretreated with either anti-NK1.1 mAb or anti-Ly49H mAb.     
    Figure 3.         Decreased Ly49H expression on m157-Tg NK cells.  
(A) Flow cytometry of splenic NK cells from m157-Tg or WT littermates. 
Representative histograms demonstrating staining of NK cells from either 
m157-Tg or WT mice for Ly49H, Ly49A, or Ly49D, as indicated. The num-
bers in the histograms represent the percentage of positive-staining cells. 
(B) Representative histograms depicting Mac1 or CD43 staining of either 
Ly49H  +   or  Ly49H  –    NK cells from m157-Tg (open histogram) and WT 
(shaded) mice. Negative control staining is shown in black histograms. 
Approximately 85  –  90% of cells stained positive for Mac1, and 99% were 
positive for CD43 in both m157-Tg and WT mice. Histograms in   Fig. 3 
(A and B  ) were gated on NK1.1  + ,  CD3     ,  CD19       cells. Histograms in   Fig. 3 B   
were generated on Ly49H  +   or  Ly49H  –    gates,  as  indicated.   1832 NK CELL TOLERANCE MEDIATED BY ACTIVATION RECEPTORS   | Tripathy et al. 
less IFN-     than Ly49H  +   cells from WT mice upon stimula-
tion with IL-12 and -18 (Fig. S6, available at http://www
.jem.org/cgi/content/full/jem.20072446/DC1). These fi  nd-
ings are consistent with a global defect in Ly49H  +   NK cell 
function with these stimuli. 
  On the other hand, there was no diff  erence in the ratio 
when splenocytes were stimulated with RMA cells (  Fig. 4 B  ) 
and treatment of splenocytes with PMA and ionomycin re-
sulted in the production of IFN-     by the Ly49H  +   NK cells 
in the m157-Tg mouse (  Fig. 4 A  ), indicating that the NK cells 
were not   “  exhausted  ”   from the apparent constant stimulation 
through Ly49H. 
Ly49 receptors (Ly49D, Ly49A, Ly49C, Ly49G, and Ly49I) 
and NKG2D were unchanged (  Fig. 3 A   and not depicted). 
As the total number of NK cells was only modestly changed, 
these data suggest that the majority of Ly49H  +   NK cells were 
not deleted (Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20072446/DC1). Comparable eff  ects on 
Ly49H expression were seen in the BM (Fig. S5). A similar 
down-regulation of Ly49H expression was previously observed 
on WT Ly49H  +   NK cells responding to m157-expressing tar-
gets in vitro (  8  –  10  ), suggesting that most, if not all, Ly49H  +   
NK cells engaged m157 in the m157-Tg mice. 
  To determine if the apparent recognition of m157 resulted 
in a maturation defect in the Ly49H  +   NK cell subset, we assessed 
various markers of development and activation. Comparable to 
WT NK cells, splenic Ly49H  +   NK cells from the m157-Tg 
mice expressed both Mac1 and CD43, markers associated with 
mature, functional NK cells (  Fig. 3 B  ). In addition, comparable 
levels of c-Kit (CD117) were expressed on Ly49H  +   BM NK 
cells from m157-Tg and WT mice (Fig. S5). Moreover, they 
did not express the CD69 activation marker (not depicted). 
Thus, even though decreased cell surface expression of Ly49H 
implied engagement with m157, the NK cells appeared to be 
mature and did not appear to be activated, which is consistent 
with an   “  anergic  ”   or hyporesponsive phenotype. 
  Functional defects of Ly49H  +   NK cells from m157-Tg mice 
  To further explore the hyporesponsive phenotype, we studied 
the function of Ly49H  +   NK cells from m157-Tg mice in vitro. 
Upon exposure to m157-expressing targets, m157-Tg Ly49H  +   
NK cells did not produce IFN-    , whereas WT Ly49H  +   NK 
cells responded (  Fig. 4 A  ).   Moreover, activated WT Ly49H  +   
NK cells showed decreased levels of Ly49H, as previously ob-
served (  8  –  10  ). Interestingly, Ly49H levels on m157-Tg NK 
cells did not change further after stimulation; their levels on 
freshly stimulated isolated NK cells were already similar to the 
levels on WT Ly49H  +   NK cells activated by m157 targets. 
  Surprisingly, m157-Tg Ly49H  +   NK cells were also defec-
tive when exposed to Ly49H-independent stimuli. Ly49H  +   
NK cells from the m157-Tg mice did not produce IFN-     
when stimulated by plate-bound anti-NK1.1 (  Fig. 4 A  ). In 
contrast, Ly49H    –    NK cells from both m157-Tg and WT lit-
termates produced similar levels of IFN-     after anti-NK1.1 
stimulation. Generally, WT Ly49H  +   NK cells were some-
what better responders to anti-NK1.1 than WT Ly49H    –    NK 
cells, an observation that was not previously reported in WT 
mice, but may be related to the propensity of NK cells that 
express one NK cell activation receptor to express another 
simultaneously (  6  ). To explore this further in terms of the 
m157-Tg mice, we compared the ratio of IFN-     produc-
tion by Ly49H  +   NK cells versus Ly49H        NK cells (  Fig. 4 B  ). 
When splenocytes were stimulated with cells stably trans-
fected with m157 (RMAs-m157) or by anti-NK1.1, the ratio 
was signifi  cantly lower for m157-Tg NK cells than for WT 
cells. Moreover, similar results were seen with Chinese ham-
ster ovary and YAC targets. Though the defect was not as 
severe, Ly49H  +   NK cells from m157-Tg mice also produced 
    Figure 4.         Decreased IFN-     production by Ly49H  +   NK cells in the 
m157-Tg mice.   (A) Representative dot plots demonstrating IFN-     pro-
duction by freshly isolated NK cells stimulated with either RMAs-m157 
cells, plate-bound anti-NK1.1 mAb (PK136), or PMA and ionomycin (P+I). 
The numbers represent the percentage of Ly49H  +   or  Ly49H       NK cells pro-
ducing IFN-    . The dot plots were gated on NK1.1  + ,  CD3     ,  CD19       cells. 
(B) The ratio of the percentage of IFN-    – producing  Ly49H +   NK cells to the 
percentage of IFN-    – producing  Ly49H       NK cells in m157-Tg mice (open 
bars) and WT mice (shaded bars). The graph represents the mean   ±   the 
SEM. Ratios were calculated after stimulation with RMAs cells, RMAs-
m157 cells, Chinese hamster ovary cells, plate-bound anti-NK1.1 (PK136), 
and YAC cells. The number of mice used in each group is displayed. The 
difference in ratio between WT and m157-Tg mice was signifi  cant (P   <   
0.05) for all stimulation groups except RMAs cells. P values determined 
using a two-tailed Student  ’  s   t   test.   JEM VOL. 205, August 4, 2008 
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in Ly49H-independent killing. To more precisely study this 
problem, we used sorted LAK cells. Sorted Ly49H  +   LAK cells 
from m157-Tg mice were unable to kill the m157-expressing 
targets (  Fig. 5 B  ). This was likely not caused by blockade of 
the Ly49H receptor by the anti-Ly49H mAb used for sorting 
because we washed and incubated the cells for 2 d after sort-
ing. In addition, sorted WT Ly49H  +   LAK cells were able to 
specifi  cally kill the m157 transfectants. Sorted Ly49H  +   LAK 
cells from both m157-Tg and WT mice were comparable 
in their ability to kill other targets through Ly49H-indepen-
dent mechanisms. These data indicate that high doses of IL-2 
could overcome the hyporesponsiveness to Ly49H-indepen-
dent stimuli, but not the hyporesponsiveness to Ly49H-de-
pendent stimuli. 
  Trans interaction is important for down-regulation 
of Ly49H and Ly49H function 
  Given that the human     -actin promoter used to generate the 
m157-Tg mouse should result in ubiquitous expression, m157 
is also expressed on NK cells themselves (unpublished data). 
This expression could result in the interaction of Ly49H and 
m157 on or in the NK cell itself (cis interaction) and give rise 
to down-regulation of Ly49H expression and other functional 
eff  ects. To determine if this was the case, we transferred WT 
BM from B6.SJL-  Ptprca   (Ly5.1) mice into irradiated Ly5.2 
mice that were either WT or m157-Tg. Down-regulation of 
Ly49H was observed on WT NK cells when WT (Ly5.1) BM 
was transferred into m157-Tg mice, but not when WT BM 
was transferred into WT mice (  Fig. 6 A  ).   The Ly49H  +   NK 
cells obtained from WT  →  m157-Tg BM chimeras were defec-
tive in IFN-     production upon stimulation with plate-bound 
  To determine if the apparent hyporesponsiveness could 
be overcome by in vivo polyclonal NK cell stimulation, mice 
were preinjected with polyinosinic:polycytidylic acid (poly 
I:C), a known inducer of type I IFNs, 24 h before in vitro 
stimulation. Ly49H  +   NK cells from the m157-Tg mice, in con-
trast to Ly49H  +   NK cells from WT mice, remained unable to 
produce IFN-     (regardless of Ly49H-dependent or Ly49H-
independent stimulation; Fig. S7, available at http://www
.jem.org/cgi/content/full/jem.20072446/DC1). Collectively, 
these results indicate that Ly49H  +   NK cells are globally hypo-
responsive when derived from mice expressing their m157 
ligand as a self-protein. 
  Functional defect of lymphokine-activated killer (LAK) cells 
from m157-Tg mice 
  Although poly I:C treatment did not overcome the hypore-
sponsiveness of the m157-Tg NK cells, we further evaluated 
their function by analysis of LAK cells grown in vitro with 
high doses of IL-2. Of note, by day four in culture, Ly49H 
levels on the LAK cells from m157-Tg were comparable to 
those on LAK cells from WT mice (Fig. S4). Also, the diff  er-
ence in the percentage of Ly49H  +   NK cells in the m157-Tg 
versus the WT LAK populations was minimal (Fig. S4). These 
data also suggest that the Ly49H  +   NK cells were not deleted 
in the m157-Tg mice. 
  Despite the normalization of Ly49H expression and per-
centage of Ly49H  +   cells, the bulk LAK cell population from 
m157-Tg mice was not able to kill m157-expressing targets 
(  Fig. 5  ).   YAC cells (  Fig. 5  ), as well as BaF-Rae-1     and OP9 
cells (not depicted), were killed to a similar extent by both 
m157-Tg and WT LAK cells, suggesting there was no defect 
    Figure 5.         NK cells from m157-Tg mice kill m157-expressing targets less effi  ciently.   (A) A standard 4-h   51  Cr-release assay was performed with 
LAK cells from m157-Tg (open symbols) or WT littermates (closed symbols). LAK cells were incubated with the indicated targets at various effector-to-
target (E:T) ratios. In BaF-m157 and RMAs-m157 graphs, both m157-expressing targets (diamonds) and nonexpressing parental lines (squares) are shown. 
The data are presented as the mean   ±   the SEM for BaF and BaF-m157 targets (  n     ≥   12 mice), RMAs and RMAs-m157 targets (  n     ≥   2 mice), and YAC targets 
(  n     ≥   14 mice). (B) A standard 4-h   51  Cr-release assay was performed with Ly49H-sorted LAK cells from m157-Tg or WT mice. The sorted Ly49H  +   LAK cells 
from WT mice (closed symbol) and m157-Tg mice (open symbol) were incubated with the indicated targets at various E:T ratios. The data are presented as 
the mean   ±   the SEM for four mice in two separate experiments.     1834 NK CELL TOLERANCE MEDIATED BY ACTIVATION RECEPTORS   | Tripathy et al. 
    Figure 6.         Trans interactions play an important role in the m157-Tg phenotypes.   (A) A dot plot of Ly49H and Ly5.2 expression on BM cells and 
splenocytes from chimeric mice. The chimeric mice were generated by injecting WT donor BM (Ly5.1) into lethally irradiated m157-Tg or WT (Ly5.2) recipients. JEM VOL. 205, August 4, 2008 
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The dot plot was gated on NK1.1  + ,  CD3     ,  CD19       cells. Note that almost all NK cells were of donor origin (Ly5.2   –   ). (B) IFN-     production by chimeric NK 
cells after stimulation with plate-bound anti-NK1.1 mAb. Chimeric mice were generated as described in   Fig. 6 A  . The numbers represent the percentage of 
Ly49H  +   or Ly49H        NK cells producing IFN-    . The dot plot was gated on NK1.1  + ,  CD3     ,  CD19       cells. (C) A standard 4-h   51  Cr-release assay was performed 
with LAK cells from WT  →  m157-Tg (open symbols) or WT  →  WT (closed symbols) chimeric mice. LAK cells were incubated with the indicated targets at 
various E:T ratios. In the RMA-m157 graph, both m157-expressing targets (diamonds) and nonexpressing parental lines (circles) are shown. The data are 
presented as the mean   ±   the SEM for BaF-m157 and YAC targets (  n   = 6  –  8 mice) and for RMA-m157 and RMAs-m157 targets (  n   =  4 – 5  mice).   
 
anti-NK1.1 mAb as compared with Ly49H  +   NK cells from 
WT  →  WT BM chimeras (  Fig. 6 B  ). In contrast, comparable 
IFN-     production was seen in the Ly49H        NK cell popula-
tions in both BM chimeras. Thus, a trans interaction between 
m157 and Ly49H is suffi   cient to alter Ly49H receptor surface 
expression and function. 
  Furthermore, transfer of mature WT spleen cells (Ly5.1) 
into m157-Tg mice (Ly5.2) resulted in a down-modulation 
of Ly49H on the donor NK cells when examined 9 d after 
transfer (  Fig. 7  ).   Moreover, there was a defect in IFN-     pro-
duction by the Ly49H  +   donor NK cells upon stimulation 
with plate-bound anti-NK1.1. These data suggest that persis-
tent engagement of Ly49H on mature NK cells is suffi   cient 
to recapitulate the functional defect of m157-Tg NK cells. 
  Continuous m157  –  Ly49H engagement is necessary 
for Ly49H dysfunction 
  To determine if functional defects persisted in vitro in the 
Ly49H  +   NK cells from the chimeric mice, we generated LAK 
cells. Unlike LAK cells from m157-Tg mice, LAK cells gen-
erated from WT  →  m157-Tg chimeric mice were able to kill 
m157-expressing targets (  Fig. 6 C  ). This capacity was com-
parable to WT  →  WT chimeric mice. Both populations also 
killed YAC cells (Ly49H-independent mechanism), indicat-
ing that absence of Ly49H  –  m157 engagement during in vitro 
culture with cytokines can reverse the hyporesponsive phe-
notype (as compared with   Fig. 5  ). These data demonstrate 
that the functional defect seen in the Ly49H  +   NK cells from 
the m157-Tg mice is not fi  xed, and suggests that hypore-
sponsiveness requires continuous engagement of the activa-
tion receptor. 
  Licensing does not reverse Ly49H  +   NK cell 
hyporesponsiveness in m157-Tg mice 
  To address if the licensing process had any eff  ect on m157-Tg 
Ly49H  +   NK cell hyporesponsiveness, we assessed the func-
tion of cells expressing Ly49C that is specifi  c for a self-MHC 
class I allele (H2K  b  ) in C57BL/6 mice. In WT mice, regard-
less of whether the freshly isolated NK cells were Ly49H  +   
or Ly49H       , anti-NK1.1 induced a higher percentage of the 
Ly49C  +   population to produce IFN-     than the Ly49C        popu-
lation (  Fig. 8 A  ), which is consistent with previous results (  17  ).   
For m157-Tg cells, the Ly49H    –    subset behaved similarly to 
the Ly49H    –    subset in WT mice, with a higher percentage 
of the Ly49C  +   population producing IFN-    . However, the 
Ly49H  +   subset in the m157-Tg mice was hyporesponsive to 
anti-NK1.1, regardless of Ly49C expression (  Fig. 8 A  ). Simi-
lar results were seen when WT  →  m157-Tg BM chimeras were 
analyzed, suggesting that trans interactions between Ly49H 
and m157 were suffi   cient for these observations (  Fig. 8 B  ). 
Finally, chimeras made from WT  →  WT mice behaved like 
WT mice (  Fig. 8 B  ). Collectively, these data demonstrate that 
licensing cannot overcome the functional hyporesponsiveness 
resulting from trans engagement of Ly49H with m157. 
    DISCUSSION   
  In this study, we provide evidence that the engagement of 
the NK cell  –  specifi  c Ly49H activation receptor with its li-
gand, which is caused by transgenic expression of m157, re-
sults in down-regulation of Ly49H receptor expression and 
  “  hyporesponsiveness  ”   in Ly49H  +   NK cell function. Similar 
results were observed by Sun and Lanier using retroviral-
transduced expression of m157 in BM stem cells (see Sun and 
Lanier [  24  ] on   p. 1819   of this issue). Any diff  erences between 
our results and theirs could be related to the means by which 
m157 was expressed. In the studies described here, the defect 
in Ly49H function was reversible and independent of the 
level of Ly49H expressed and the percentage of Ly49H  +   NK 
cells in the m157-Tg mice. 
  The hyporesponsiveness in Ly49H  +   NK cell function was 
of two types, with one specifi  cally involving only the Ly49H 
pathway. The second extended beyond stimulation through 
the Ly49H receptor because we also observed global defects 
in signaling by other activation receptors that do not signal 
through Ly49H and DAP12, and use other signaling chains, 
as well as responses to cytokines, such as IL-12 and -18. More-
over, stimuli that bypass proximal activation signals could 
equally stimulate normal and hyporesponsive cells, suggesting 
that the signaling defect is distal to the signaling chains, but 
upstream of signals mimicked by PMA and ionomycin. It is 
possible that continuous engagement of Ly49H with m157 
results in negative feedback that leads to the down-regulation 
of not only Ly49H but also downstream signaling molecules 
(e.g., protein tyrosine kinases) that are shared by multiple ac-
tivation pathways. Alternatively, continuous engagement of 
Ly49H with m157 could result in the sequestration of down-
stream signaling molecules that are shared by multiple activa-
tion receptor pathways. In this manner, NK cells could be 
rendered hyporesponsive to multiple activation pathways. Clearly, 
future studies will need to be performed to identify the mech-
anisms of global hyporesponsiveness. Regardless of the mech-
anism, these data, taken together with data from Sun and Lanier 
and others (  24  –  27  ), lend strong support to the hypothesis that 
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tion. The inability to reverse the global hyporesponsiveness 
of Ly49H  +   NK cells with poly I:C is relevant to MCMV in-
fections because poly I:C induces Toll-like receptor stimu-
lation of dendritic cells, resulting in type I IFN release and 
concomitant NK cell stimulation (  28  ). A similar pathway is 
activated in MCMV infections and is required for NK cell 
control of MCMV, even when Ly49H is present (  29, 30  ). 
Thus, hyporesponsiveness through an activation receptor may 
not be overcome by certain proinfl  ammatory cytokines, ac-
counting for the persistent defect in MCMV clearance in 
the m157-Tg mice despite host production of cytokines dur-
ing infection. 
  Functional hyporesponsiveness appeared to require con-
tinued receptor  –  ligand interaction. Persistent in vivo interaction 
in trans was suffi   cient for global Ly49H  +   NK cell hypore-
sponsiveness, as revealed by our BM chimeric mouse experiments 
and adoptive transfer of mature WT NK cells. Interestingly, 
hyporesponsiveness caused by trans eff  ects was reversed dur-
ing in vitro culture with IL-2. For example, if the NK cells 
did not express m157, such as NK cells from WT  →  m157-Tg 
BM chimeric mice, then in vitro culture in IL-2 reversed 
hyporesponsiveness. On the other hand, selective hypore-
sponsiveness of the Ly49H pathway persisted even in the pres-
ence of high doses of IL-2 if we used m157-Tg NK cells in 
which receptor  –  ligand interactions likely continued via cis ef-
fects or trans interactions with neighboring cells. The putative 
cis eff  ects may be another example by which such interactions 
could aff  ect NK cell receptor function as recently described 
(  17, 31  ) and reviewed (  32  ). In either case, these persistent ef-
fects on Ly49H function did not appear to be caused by low-
ered levels of Ly49H expression because nearly equal levels 
of Ly49H were seen when WT and m157-Tg NK cells were 
confer a generalized state of hyporesponsiveness to the NK cell, 
as previously hypothesized (  15  ). 
  Interestingly, our data suggest that hyporesponsiveness can 
occur when mature Ly49H  +   NK cells are exposed to m157. 
Even when they developed in a ligandless environment, WT 
Ly49H  +   NK cells became hyporesponsive when transferred 
into the m157-Tg mice. We examined NK cells 9 d after 
transfer when the cells had down-regulated Ly49H expression, 
but were no longer making IFN-     at baseline, suggesting that 
they specifi  cally became hyporesponsive by engagement of 
Ly49H, and that maturation in the m157-Tg environment 
was not necessary to demonstrate the hyporesponsive pheno-
type. This surprising result requires additional examination 
because it also suggests that WT NK cells may show a state of 
hyporesponsiveness after activation receptor triggering during 
a normal innate immune response. 
  In the m157-Tg NK cells, the global functional hypore-
sponsiveness had in vivo consequences because MCMV con-
trol and m157-Tg BM rejection were aff  ected. Although it is 
possible that responses of m157-Tg mice after MCMV infec-
tion are partially a result of the decreased Ly49H expression 
on NK cells, hyporesponsiveness of the Ly49H  +   NK cells likely 
also plays a major role. Our in vitro data corroborate our in 
vivo fi  ndings, indicating an NK cell functional impairment, 
as we demonstrate a defect in the Ly49H  +   NK cells to produce 
IFN-     in response to Ly49H-mediated as well as non-Ly49H  –
  mediated stimuli. Furthermore, LAK cells from m157-Tg mice 
were defective in killing m157-expressing targets, even when 
normalized for the number of Ly49H  +   NK cells. 
  Of note, the global eff  ects of Ly49H engagement could 
be overcome by cytokines in certain situations (high levels of 
IL-2 in vitro), but not in others, such as poly I:C administra-
    Figure 7.         Mature donor WT Ly49H  +   NK cells display defective phenotype upon transfer into m157-Tg mice.   (A) A dot plot of Ly49H and Ly5.1 
expression on NK cells from adoptively transferred mice. The mice were generated by injecting WT donor splenocytes (Ly5.1) into WT (Ly5.2) or m157-Tg 
(Ly5.2) recipients. The dot plot was gated on NK1.1  + ,  CD3       cells. (B) IFN-     production by donor NK cells after stimulation with plate-bound anti-NK1.1. 
The numbers represent the percentage of Ly49H  +   or  Ly49H       cells producing IFN-    . The dot plot was gated on NK1.1  + ,  CD3     ,  CD19     ,  Ly5.1 +   (donor)  NK 
cells. (C) The ratio of the percentage of IFN-    – producing  Ly49H +   NK cells to the percentage of IFN-    – producing  Ly49H       NK cells from WT (fi  lled,   n   = 3) or 
m157-Tg (open,   n   = 5) mice after stimulation with plate-bound anti-NK1.1. The results are presented as the mean   ±   the SEM.     JEM VOL. 205, August 4, 2008 
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  There are some similarities, but also notable diff  erences 
between our current study and previous investigations of mice 
with transgenic expression of ligands for another NK cell ac-
tivation receptor, NKG2D (  26, 27  ). In transgenic mice con-
stitutively expressing Rae-1     or MICA, down-regulation of 
NKG2D and generalized defects in NK cell function were 
observed. Moreover, trans eff  ects on NKG2D were noted 
cultured in vitro. Collectively, these data indicate that the 
NK cell hyporesponsive state can be manifested by the pres-
ence of the ligand in trans and potentially in cis, and may be 
aff  ected by the cytokine milieu, but persistent interactions 
between activation receptor and its ligand may result in per-
manent hyporesponsiveness of the given activation recep-
tor pathway. 
    Figure 8.         Licensing does not reverse Ly49H  +   hyporesponsiveness in m157-Tg mice.   (A)  IFN-    production by NK cells from WT (left) or 
m157-Tg (right) after stimulation with plate-bound PK136. The fi  rst dot plot (Ly49H vs. side scatter) was gated on NK (NK1.1  + ,  CD3     ,  CD19     )  cells. 
The boxes represent the Ly49H  +   and  Ly49H       subsets used in further analysis for Ly49C and IFN-     expression. (B) IFN-     produced by NK cells from 
WT  →  WT and WT  →  m157-Tg chimeric mice. The analysis was identical to   Fig. 8 A  . The numbers represent the percentage of Ly49H  +   or  Ly49H       NK 
cells producing IFN-   .   1838 NK CELL TOLERANCE MEDIATED BY ACTIVATION RECEPTORS   | Tripathy et al. 
tion receptor Ly49H with its ligand (m157) expressed as self. 
However, it is theoretically possible that licensing could over-
come the activation receptor-induced hyporesponsive state if 
the interactions between the activation receptor and its ligand, 
or between the relevant inhibitory receptor and MHC class I, 
were either decreased or increased, respectively. For exam-
ple, affi   nity diff  erences could modulate the resultant func-
tional competence of the NK cell, although recent biophysical 
studies indicate that the affi   nity of Ly49H for m157 approxi-
mates that of Ly49 receptors for MHC class I ligands (  K    d   = 
    1   μ  M) (  47  ). Similarly, it is possible that the expression lev-
els of the relevant receptors and ligands could aff  ect avidity, 
or the simultaneous participation of several diff  erent recep-
tors on an individual NK cell may be relevant. However, the 
current data suggest that hyporesponsiveness induced by a self-
specifi  c activation receptor may be diffi   cult to overcome by 
licensing through a self-MHC class I  –  specifi  c inhibitory recep-
tor, i.e., the data currently do not support the disarming model. 
  Nevertheless, the interactions of activation receptors 
with their self-specifi  c ligands do result in NK cell tolerance. 
Perhaps this represents another mechanism for self-tolerance, 
distinct from licensing by self-MHC via the   “  arming  ”   model. 
NK cell tolerance would therefore be achieved by multiple 
mechanisms, somewhat analogous to central versus periph-
eral tolerance for T cells (  48, 49  ), for example. Clearly, fur-
ther studies are warranted because NK cell tolerance for 
self appears to be more complex than originally conceptual-
ized (  16  ). 
    MATERIALS AND METHODS   
  Mice.     C56BL/6 mice were obtained from the National Cancer Institute 
(Bethesda, MD). B6.      2  M      /      mice and B6.SJL-  Ptprca   (CD45.1, Ly5.1) mice 
were purchased from The Jackson Laboratory. Mice were maintained under 
specifi  c pathogen  –  free conditions and used after 8 wk of age. Animal studies 
were approved by the Animal Studies Committee at Washington University 
(St. Louis, MO). 
  m157 transgenic mice.     A transgenic construct for the expression of m157 
was generated as follows: the m157 cDNA was obtained by PCR (amplifi  ca-
tion of a 1,000-bp m157 fragment from pHSE3    m157 using primers that 
contained NotI restriction sites) (  9, 10  ). The resulting m157 fragment was 
cloned into the pCMV plasmid (BD Biosciences) digested with NotI. A 
1,400-bp fragment from pCMVm157 with XhoI and HindIII ends was 
cloned into the pBAP vector that had been digested with SalI and HindIII 
to generate pBAPm157. Microinjection of the purifi  ed ClaI-digested frag-
ment from pBAPm157 was performed by the Mouse Genetics Core at 
Washington University supported by the Rheumatic Diseases Core Center. 
DNA obtained from tail tissue of the founders and off  spring were screened 
by PCR using the following primer sets that generated a 250-bp fragment: 
m157-F (5    -TCAACTTCCGACGCAAAAGAAAT-3    ) and m157-R (5    -
ACCGTCGATTCGTCAGTAACG-3    ). Peripheral blood lymphocytes 
were also stained for the expression of m157 using a biotinylated mAb against 
m157 (6H121) that has been previously described (  10  ). 
  Virus and infection of mice.     Smith strain MCMV was a generous gift of 
H. Virgin (Washington University). A salivary gland stock of MCMV gener-
ated in our laboratory was used in all of the in vivo experiments (  50  ). For the 
survival curve, the mice were injected i.p. with 1.5   ×   10  5   PFU MCMV. 
The percentage of mice surviving within each group was determined daily. 
through examination of mice with tissue-specifi  c expression 
of Rae-1     (  27  ). These results are similar to the Ly49H down-
regulation and the defects in the Ly49H  +   NK cells in m157-
Tg mice that were observed both by us and by Sun and 
Lanier (  24  ). However, in the Rae-1     and MICA-Tg models, 
all NK cells were altered with potential contributions from 
soluble NKG2D ligands (  26, 27  ). In contrast, in the m157-Tg 
mice, only the Ly49H  +   subset of NK cells was altered, indi-
cating a specifi  c eff  ect caused by receptor engagement. In addi-
tion, there was no evidence for soluble m157 (unpublished data). 
Furthermore, it is possible that other immune cells expressing 
NKG2D may have contributed to the NKG2D functional 
eff  ects noted in vivo in the Rae-1     or MICA-Tg mice. For 
example, there was increased susceptibility to squamous cell 
cancers in the Rae-1    -Tg mice and increased susceptibility 
of MICA-Tg mice to MICA-expressing tumors, but tumor 
resistance in these models can also be mediated by          T cells 
and          T cells that express NKG2D (  26, 27  ). Similarly, there 
was increased susceptibility of the MICA-Tg mice to   Listeria   
infection, but dysfunction of other cell types, such as NKG2D-
expressing CD8  +   T cells, may contribute to the phenotype 
observed (  26  ). 
  NKG2D and its ligands have additional layers of complex-
ity. Mouse NKG2D is expressed on all NK cells in two diff  er-
ent isoforms, (  33  –  35  ) and two diff  erent signaling molecules 
(DAP12 and DAP10) (  36  ). Also, mouse NKG2D has multiple 
endogenous ligands, including those that are constitutively ex-
pressed as well as being up-regulated on   “  stressed  ”   cells (  37  –  41  ). 
In addition, NKG2D ligands can be expressed as soluble forms 
that modulate NKG2D function (  42  ). Finally, NKG2D itself 
is expressed on non-NK cell populations (  40  ). Thus, although 
prior studies of NKG2D ligand-Tg mice demonstrate NKG2D-
induced hyporesponsiveness, our current studies demonstrate 
that the in vivo functional eff  ects of persistent activation receptor 
interactions, specifi  cally on NK cell functions (because Ly49H 
is expressed only on NK cells), has no known endogenous 
ligands, and that m157 does not display any detectable binding 
to other cells in C57BL/6 mice. 
  Previous work has also demonstrated that Ly49D  +   NK 
cells appear to be defective in mice expressing H2D  d   (  25  ), a 
putative ligand for Ly49D (  43, 44  ). However, physical inter-
action between Ly49D and H2D  d   has been diffi   cult to detect 
(  45  ), suggesting that H2D  d   may not be a Ly49D ligand or 
that other, as yet undefi  ned, parameters aff  ect H2D  d   binding 
to Ly49D. In addition, H2D  d   is recognized by other Ly49 
inhibitory receptors (  46  ), suggesting that its eff  ect on Ly49D  +   
NK cells could be caused by other receptor  –  ligand interactions. 
On the other hand, the Ly49H-m157 interaction exploited 
for the studies reported here does not appear to be subject to 
these concerns. 
  Our studies also provide additional insight into the issue 
of NK cell tolerance with respect to MHC class I because we 
provide a test of the   “  disarming  ”   model. Herein, we demon-
strated that licensing (engagement of inhibitory Ly49 recep-
tor with self-MHC class I molecules) could not overcome 
the hyporesponsiveness caused by engagement of the activa-JEM VOL. 205, August 4, 2008 
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50 ng/ml IL-18 for 4 h in the presence of GolgiPlug. Splenocytes were 
stained for NK1.1, CD3, CD19, and Ly49H as described in the Flow cy-
tometry section. Staining for Ly49C was done using digoxigenin-labeled 
anti-Ly49C followed by FITC-D1-22 (anti-digoxin; Sigma-Aldrich). To 
block nonspecifi  c binding of antibodies to Fc receptors, all antibodies were 
diluted in the presence of mAb 2.4G2 (anti-Fc     receptor II/III; American 
Type Culture Collection). Cells were fi  xed and permeabilized with Cyto-
fi   x/Cytoperm kit (BD Biosciences), and then stained with either Alexa 
Fluor 488-XMG1.2 (anti-IFN-    ; BD Biosciences) or PE-Cy7-XMG1.2 
(anti-IFN-    ; BD Biosciences) diluted in perm/wash buff   er (BD Biosci-
ences). Cells were analyzed using a FACSCalibur or FACSCanto cytometer 
(BD Biosciences) gating on NK1.1  +  , CD3       , CD19        populations. 
  Cytotoxicity assays.     Generation of LAK cells, sorted Ly49H  +   and Ly49H        
NK cells, and standard 4-h   51  Cr release assays were performed as previously 
described (  6, 45  ). For sorting assays, LAK cells were sorted on day seven of 
culture by staining with biotinylated 3D10, followed by PE-streptavidin 
(BD Biosciences). After sorting, LAK cells were washed and cultured for 2 d 
before use in cytotoxicity assays. 
  Statistical analysis.     Survival data were analyzed by the Mantel  –  Haenszel 
test, with death as the primary variable using Prizm software (GraphPad). 
The data in   Fig. 2   were analyzed using the Mann-Whitney test with Prizm 
software. The remainder of the data were analyzed with Excel X for Mac 
(Microsoft). Error bars in the fi  gures represent the SEM. 
  Online supplemental material.     Fig. S1 depicts the construct used to gen-
erate the m157-Tg mouse, as well as identifi  cation of m157-Tg mice by 
PCR analysis of genomic DNA, expression of m157 on peripheral blood, 
and BM lymphocytes from the mouse. Fig. S2 compares splenocyte and NK 
cell counts from WT and m157-Tg mice. Fig. S3 demonstrates that the 
m157-Tg mouse can reject       2  m      /      BM cells. Fig. S4 demonstrates that IL-2 
stimulation results in a normalization of Ly49H expression on m157-Tg NK 
cells. Fig. S5 demonstrates cell surface expression of Ly49H, c-Kit, Mac1, 
and CD43 on BM NK cells. Fig. S6 compares IFN-     production after stim-
ulation of WT and m157-Tg NK cells with IL-12 and -18. Fig. S7 compares 
production of IFN-     by NK cells from WT or m157-Tg mice treated with 
poly I:C. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20072446/DC1. 
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Moribund mice were killed per institutional guidelines. To measure splenic 
titers, mice were injected i.p. with 2   ×   10  4   PFU MCMV, and titer was de-
termined by plaque assays, as previously described (  51  ). In brief, spleens 
from infected mice were obtained on day 3 after infection. They were 
placed in 1 ml of DME containing 10% calf serum (HyClone), 100 U/ml 
penicillin, 100   μ  g/ml streptomycin, and 2 mM glutamine and frozen at 
  –  80  °  C until assayed. Spleens were thawed and homogenized with Dounce 
homogenizer on ice. Serial dilutions of the splenic lysate were then used 
to infect a monolayer of NIH-3T12 cells in triplicate on 6-well plates. 
After a 1-h incubation, the infected cells were overlaid with overlay media 
(DME, 5% calf serum, 1% Hepes, and 0.5% noble agar). On day three, 
the infected cells were again overlaid with overlay media. Titers were read 
on day four by two independent observers using a light microscope at 
4  ×   magnifi  cation. 
  Adoptive transfer into neonatal mice.     Recipients were neonatal (3  –  4 d 
old) C57BL/6 mice. Before the experiments, neonatal mice from several lit-
ters were pooled and randomly redistributed to lactating mothers. Groups of 
5  –  7 mice were given an i.p. injection of PBS (vehicle control), 5   ×   10  7   WT 
splenocytes, or 5   ×   10  7   m157-Tg splenocytes. The cells were injected in 
50   μ  l of PBS. The next day, the mice were challenged with 870  –  1,000 PFU 
of MCMV i.p. in a total volume of 50   μ  l. The percentage of mice surviving 
in each group was determined daily. 
  BM graft rejection, BM chimeras, and splenocyte transfers.     WT or 
m157-Tg mice were irradiated with 9.5 Gy. Irradiated WT or m157-Tg 
mice were injected via tail vein with 4   ×   10  6  , 2   ×   10  6  , 10  6  , or 5   ×   10  5   BM 
cells isolated from the femora and tibiae of WT, m157-Tg, or     2m      /      mice. 
5 d later, the mice were injected via the tail vein with 3   μ  Ci   125  I-deoxyuri-
dine (GE Healthcare). After 20  –  24 h, the mice were killed and the spleens 
were removed, rinsed extensively with PBS, and counted in a gamma coun-
ter (Gamma 5500; Beckman Coulter). Mice pretreated with anti-NK1.1, 
anti-Ly49H, or mouse anti  –  rat mAbs were injected i.p. 2 d before irradiation 
with 200   μ  g of the respective mAb. For BM chimera assays, BM cells were 
prepared from femora and tibiae of B6.SJL-  Ptprca   (Ly5.1) mice. A total of 
10  7   BM cells was injected via tail vein into 9.5 Gy irradiated WT (Ly5.2) or 
m157-Tg (Ly5.2) mice. The spleen cells were analyzed at least 6 wk after 
transplantation. For the adoptive transfer of mature splenocytes, 4   ×   10  7   
splenocytes from WT (Ly5.1) mice were injected via tail vein into WT 
(Ly5.2) or m157-Tg (Ly5.2) mice. 90 d later, the mice were killed, spleens 
were removed, and splenic NK cells were assayed for cell surface expression 
and cytokine production. 
  Flow cytometry.     Spleen cell suspensions were generated and stained for 
cell surface markers as previously described (  9  ). The following antibodies 
were obtained from BD Biosciences: APC-PK136 (anti-NK1.1), PerCP-
Cy5.5-145-2C11 (anti-CD3) and PerCP-Cy5.5-1D3 (anti-CD19), and 
FITC-M1/70 (anti-CD11b) and FITC-S7 (anti-CD43). Biotinylated-3D10 
(anti-Ly49H) (  6  ), FITC-4E4 (anti-Ly49D) (  52  ), 4LO3311 (anti-Ly49C) 
(  53  ), and FITC-JR9 (anti-Ly49A) (  6  ) were purifi  ed from hybridomas and 
conjugated to FITC using FITC-celite (Calbiochem) or biotin using EZ-
Link Sulfo-NHS-LC-LC-Biotin (Thermo Fisher Scientifi  c) according to 
manufacturer  ’  s protocol. Digoxigenin labeling of anti-Ly49C was performed 
according to manufacturer  ’  s protocol using the DIG Protein Labeling kit 
(Roche). To block nonspecifi  c binding of antibodies to Fc receptors, all anti-
bodies were diluted in the presence of mAb 2.4G2 (Fc     II/III receptor; 
American Type Culture Collection). 
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